{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Comprehensive+molecular+panel+test", "query": { "intervention": "Comprehensive molecular panel test" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 8, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T09:16:42.684Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06321796", "title": "Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pitt Hopkins Syndrome" ], "interventions": [ { "name": "MTP-101P", "type": "COMBINATION_PRODUCT" }, { "name": "Vancomycin", "type": "COMBINATION_PRODUCT" }, { "name": "Magnesium Citrate", "type": "COMBINATION_PRODUCT" }, { "name": "Antacid", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo MTP-101P", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo Vancomycin", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Gut-Brain-Axis Therapeutics Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "5 Years to 55 Years" }, "enrollment_count": 20, "start_date": "2024-02-27", "completion_date": "2025-05", "has_results": false, "last_update_posted_date": "2024-03-20", "last_synced_at": "2026-09-03T09:16:42.684Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06321796" }, { "nct_id": "NCT05826964", "title": "Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer", "ER-positive Breast Cancer", "HER2-negative Breast Cancer", "Metastatic Breast Cancer" ], "interventions": [ { "name": "AI+CDK4/6i", "type": "DRUG" }, { "name": "SERD+CDK4/6i", "type": "DRUG" }, { "name": "mTOR inhibitor + AI", "type": "DRUG" }, { "name": "mTOR inhibitor + SERD", "type": "DRUG" }, { "name": "mTOR inhibitor + Selective estrogen receptor modulator", "type": "DRUG" }, { "name": "PI3K inhibitor + SERD", "type": "DRUG" }, { "name": "PI3K inhibitor + AI", "type": "DRUG" }, { "name": "Chemotherapy", "type": "DRUG" }, { "name": "Oral SERD", "type": "DRUG" }, { "name": "PARPi", "type": "DRUG" }, { "name": "AKT inhibitor", "type": "DRUG" }, { "name": "Step 3 Arm 2", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2023-06-12", "completion_date": "2029-07-31", "has_results": false, "last_update_posted_date": "2026-01-13", "last_synced_at": "2026-09-03T09:16:42.684Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05826964" }, { "nct_id": "NCT05703243", "title": "Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting (\"DINOSAur II\")", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stage III Solid Tumors", "Stage IV Solid Tumors" ], "interventions": [ { "name": "Comprehensive liquid molecular panel test", "type": "DIAGNOSTIC_TEST" }, { "name": "EORTC QLQ-30", "type": "OTHER" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Glendale Adventist Medical Center d/b/a Adventist Health Glendale", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 572, "start_date": "2023-02-01", "completion_date": "2025-01-01", "has_results": false, "last_update_posted_date": "2023-03-03", "last_synced_at": "2026-09-03T09:16:42.684Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05703243" }, { "nct_id": "NCT05692466", "title": "Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting (\"DINOSAur\")", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stage III Solid Tumors", "Stage IV Solid Tumors" ], "interventions": [ { "name": "Comprehensive molecular panel test", "type": "DIAGNOSTIC_TEST" }, { "name": "EORTC QLQ-30", "type": "OTHER" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Glendale Adventist Medical Center d/b/a Adventist Health Glendale", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 572, "start_date": "2023-02-01", "completion_date": "2025-11-01", "has_results": false, "last_update_posted_date": "2023-03-03", "last_synced_at": "2026-09-03T09:16:42.684Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05692466" }, { "nct_id": "NCT05368038", "title": "ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Acid Sphingomyelinase Deficiency", "Ceroid Lipofuscinosis, Neuronal, 2", "Cerebrotendinous Xanthomatosis", "Fabry Disease", "GM1 Gangliosidosis", "Gaucher Disease", "Lysosomal Acid Lipase Deficiency", "Metachromatic Leukodystrophy", "Mucopolysaccharidosis II", "Mucopolysaccharidosis III-B", "Mucopolysaccharidosis IV A", "Mucopolysaccharidosis VI", "Mucopolysaccharidosis VII", "Niemann-Pick Disease, Type C" ], "interventions": [ { "name": "Confirmatory Testing", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Albert Einstein College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "4 Weeks", "sex": "ALL", "summary": "Up to 4 Weeks" }, "enrollment_count": 100000, "start_date": "2021-05-10", "completion_date": "2029-08-31", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-09-03T09:16:42.684Z", "location_count": 9, "location_summary": "Brooklyn, New York • Manhasset, New York • New York, New York + 2 more", "locations": [ { "city": "Brooklyn", "state": "New York" }, { "city": "Brooklyn", "state": "New York" }, { "city": "Manhasset", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05368038" }, { "nct_id": "NCT06090513", "title": "Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Advanced Cancer", "Solid Tumor, Adult", "Myeloid Malignancy" ], "interventions": [ { "name": "Comprehensive Genomic Profile testing; ELIA software; Molecular Genetic Pathologist consultation", "type": "COMBINATION_PRODUCT" }, { "name": "limited genetic testing or no testing", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "COMBINATION_PRODUCT", "DIAGNOSTIC_TEST" ], "sponsor": "Bien-Willner Physicians Group PA", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2024-10-18", "completion_date": "2026-10-18", "has_results": false, "last_update_posted_date": "2024-08-06", "last_synced_at": "2026-09-03T09:16:42.684Z", "location_count": 1, "location_summary": "Rock Hill, South Carolina", "locations": [ { "city": "Rock Hill", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06090513" }, { "nct_id": "NCT06503978", "title": "Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Autism Spectrum Disorder", "Gastro-Intestinal Disorder", "Constipation", "Diarrhea" ], "interventions": [ { "name": "MTP-101P", "type": "COMBINATION_PRODUCT" }, { "name": "Vancomycin", "type": "COMBINATION_PRODUCT" }, { "name": "Miralax", "type": "COMBINATION_PRODUCT" }, { "name": "Antacid", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo MTP-101P", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo Vancomycin", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Gut-Brain-Axis Therapeutics Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "4 Years to 18 Years" }, "enrollment_count": 60, "start_date": "2024-08-20", "completion_date": "2026-08-17", "has_results": false, "last_update_posted_date": "2024-09-25", "last_synced_at": "2026-09-03T09:16:42.684Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06503978" }, { "nct_id": "NCT04058132", "title": "Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Traumatic Brain Injury" ], "interventions": [ { "name": "Sildenafil Citrate 50Mg Tab", "type": "DRUG" }, { "name": "functional Near-infrared Spectroscopy (fNIRS)", "type": "DEVICE" }, { "name": "Carbon Dioxide (CO2) 5%", "type": "OTHER" }, { "name": "Neuropsychological Assessments", "type": "OTHER" }, { "name": "Gadolinium contrast infusion", "type": "DRUG" }, { "name": "Blood sample collection for research purposes", "type": "PROCEDURE" }, { "name": "Structural brain Magnetic Resonance Imaging (MRI", "type": "OTHER" } ], "intervention_types": [ "DRUG", "DEVICE", "OTHER", "PROCEDURE" ], "sponsor": "Uniformed Services University of the Health Sciences", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 1, "start_date": "2019-08-09", "completion_date": "2020-03-01", "has_results": false, "last_update_posted_date": "2024-02-28", "last_synced_at": "2026-09-03T09:16:42.684Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04058132" } ] }